Type I Diabetes
- Do you have Type I Diabetes (Insulin Dependent)?
- Are you struggling with low blood sugar (hypoglycemia)?
- Are 18 years of age or older?
- Have lived with T1D for at least five years?
- Trial participation is at no cost to you.
The CATT1 study will look at whether the study drug, cadisegliatin (also called TTP399), can reduce the frequency of low blood sugar (hypoglycemia) in adults with type 1 diabetes mellitus (T1DM).
The study drug is a tablet taken by mouth. It is designed to stimulate the liver and improve the liver’s ability to store sugar from food, which may reduce episodes of high or low blood sugar.
The study drug is a tablet taken by mouth. It is designed to stimulate the liver and improve the liver’s ability to store sugar from food, which may reduce episodes of high or low blood sugar.
Study-related procedures, tests, and doctor visits are provided at no cost to you. Reimbursement for study-related expenses, such as meals, parking, or transportation may be available.
We are happy to answer any questions you or your loved ones have and to see if you may be able to participate.